Proprietary pharmaceuticals to the North East Purchasing Group.
UK-Reading: Various medicinal products
Section I: Contracting authority
Commercial Medicines Unit
Premier House, 60 Caversham Road
Contact point(s): via CMU Bravosolution website
For the attention of: Sarah Blackman
RG1 7EB Reading
General address of the contracting authority: https://cmu.bravosolution.co.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Other: Public Procurement
Section II: Object of the contract
Main site or location of works, place of delivery or of performance: The framework agreement is intended for use by the Department of Health and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Documents 10a and 10b in the ITT Documents for the list of Purchasing Points.
NUTS code UK
Duration of the framework agreement
Duration in months: 24
Justification for a framework agreement, the duration of which exceeds four years: NE – 1.7.2013 to 30.6.2015 – Plus options to extend for up to a further 24 months.
All regions – Elvitegravir / Cobicistat / Emtricitabine / Tenofovir 150MG/150MG/200MG/300MG Tablets – 1.7.2013 to various end dates.
The total maximum duration of the framework agreement will be no more than 48 months.
Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT: 140 000 000 GBP
1.7.2013 to 30.6.2015 – with options to extend for a further 24 months.
33690000, 33693000, 85149000
Section III: Legal, economic, financial and technical information
Description of particular conditions: Refer to the ITT, Document No. 3 Conditions of Contract.
Please refer to the award criteria contained in the ITT.
Section IV: Procedure
Section VI: Complementary information
1) Submission of expression of interest and procurement specific information.
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk
Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
— accept the terms and conditions and click continue,
— enter your correct business and user details,
— note the username you chose and click “Save” when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select “Response to ITT”;
c. select “ITTs Open To All Suppliers”;
d. access listing related to this procurement Proprietary pharmaceuticals to the itt_29471 North East Purchasing Group and view details;
e. click on “Express interest” button at the top of the page.
f. Once you have expressed interest, the ITT will move to “My ITTs”, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the “Publish” button.
1.3) For any support in registering on the portal or submiting your expression of interest please contact the eTendering Help-desk at +44 8003684850 or firstname.lastname@example.org
2) Entering general supplier information.
To manage and assess supplier information the Contracting Authority requests candidates provide their supplier profile in the NHS Supplier Information Database (sid4health) as follows:
2.1) Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4health. This normally is provided within 48 hours but may take up to 5 days (turnaround times will vary from country to country), so please ensure this step is completed as soon as possible. The D-U-N-S® number is the standard supplier coding for the NHS and must be obtained for use in all trading with the NHS. Check to see if your company has a D-U-N-S® Number on the Sid4health registration page.
2.2) Candidates must go to the following web page http://www.sid4health.nhs.uk/home.action and select the Register Supplier Organisation on the left of the page. Key in details as shown to search for your D-U-N-S® Number. If you are not on their database click on the link at the bottom of the page to obtain a number from D&B.
2.3) Once registration has been authorised by the sid4health administrator and after receiving logon details, access the Profile Management area and create and validate your sid4health company profile. (Candidates must publish at least one validated profile to make their profile available for buyers to view generally – see the Help page on sid4health within Profile Management for more details).
2.4) Candidates should ensure all the mandatory fields of their sid4health profile are completed. Failure to comply with the completion of all mandatory fields could result in the elimination from the procurement process at this stage. D&B data will be supplied automatically by D&B.
2.5) Once a candidate has ensured that all the required fields are completed and the profile has been validated. They must add the profile to the Request to Participate list ID number T1200-299] and named Proprietary pharmaceuticals to the North East Purchasing Group Select ‘View all request to participate lists’ on the left menu and search/select this list. Select the Join button to the right of the list and then select the validated profile to allocate to this procurement (you may have more than one validated profile as you may have different information held against your profile for different procurements)
2.6) Where access to sid4health is unavailable, please contact the sid4health Helpdesk at: email@example.com
The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
Potential suppliers should note that, in accordance with the Government’s policies on transparency, the Contracting Authority intends to publish the OJEU, ITT and the text of final framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: http://www.cabinetoffice.gov.uk/resource-library/guidance-transparency
VI.5)Date of dispatch of this notice:8.1.2013